Try our beta test site
1 study found for:    17641366 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer
Condition: Hepatocellular Cancer
Interventions: Drug: Sorafenib;   Procedure: radiofrequency ablation

Study has passed its completion date and status has not been verified in more than two years.